RFG Advisory LLC Sells 28,915 Shares of The Chemours Company $CC

RFG Advisory LLC trimmed its position in shares of The Chemours Company (NYSE:CC) by 51.3% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 27,405 shares of the specialty chemicals company’s stock after selling 28,915 shares during the period. RFG Advisory LLC’s holdings in Chemours were worth $604,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Baird Financial Group Inc. bought a new stake in shares of Chemours during the 1st quarter worth approximately $148,000. Royal Bank of Canada increased its stake in Chemours by 6.8% in the first quarter. Royal Bank of Canada now owns 585,702 shares of the specialty chemicals company’s stock valued at $7,926,000 after acquiring an additional 37,382 shares during the last quarter. AQR Capital Management LLC acquired a new position in Chemours during the first quarter valued at approximately $161,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Chemours by 149.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,243 shares of the specialty chemicals company’s stock valued at $593,000 after purchasing an additional 25,899 shares in the last quarter. Finally, Empowered Funds LLC bought a new stake in Chemours during the first quarter worth $403,000. 76.26% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on CC. Alembic Global Advisors reiterated an “overweight” rating and issued a $30.00 price target on shares of Chemours in a research note on Wednesday, May 13th. Mizuho set a $30.00 price objective on Chemours in a research report on Wednesday, May 6th. Morgan Stanley raised their price objective on Chemours from $17.00 to $21.00 and gave the company an “equal weight” rating in a research note on Monday, May 11th. Zacks Research upgraded Chemours from a “strong sell” rating to a “hold” rating in a research report on Friday, April 24th. Finally, JPMorgan Chase & Co. boosted their target price on Chemours from $17.00 to $22.00 and gave the stock a “neutral” rating in a research note on Thursday, May 21st. Six research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $24.60.

Chemours Stock Performance

NYSE CC opened at $20.04 on Tuesday. The firm’s fifty day moving average price is $22.81 and its two-hundred day moving average price is $19.09. The stock has a market cap of $3.01 billion, a PE ratio of -7.59 and a beta of 1.40. The company has a debt-to-equity ratio of 18.98, a quick ratio of 0.87 and a current ratio of 1.82. The Chemours Company has a fifty-two week low of $10.44 and a fifty-two week high of $28.67.

Chemours (NYSE:CC) last announced its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.10. Chemours had a positive return on equity of 52.49% and a negative net margin of 6.82%.The company had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.40 billion. During the same period in the prior year, the company earned $0.13 EPS. Chemours’s revenue was up 1.0% compared to the same quarter last year. On average, equities analysts expect that The Chemours Company will post 1.07 EPS for the current fiscal year.

Chemours Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Sunday, May 17th were given a $0.0875 dividend. The ex-dividend date was Friday, May 15th. This represents a $0.35 annualized dividend and a yield of 1.7%. Chemours’s dividend payout ratio (DPR) is currently -13.26%.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.